$EVFM Balance Sheet | Understand Stock

$EVFM

$0.01 +$0.00 (2.67%) Close

$EVFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Restricted cash and cash equivalents
Trade accounts receivable, net
Inventories
Prepaid and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Intangible asset, net (Note 7)
Other noncurrent assets
Total assets
Liabilities, convertible and redeemable preferred stock and stockholders’ deficit
Current liabilities:
Accounts payable
Fair Value Amount
Baker Notes
Adjuvant Notes
Baker Bros Notes
Related Party
Adjuvant Notes
Total fair Value Amount

Term notes payable - recognized at fair value
Convertible notes payable - Adjuvant (Note 4)
Short-term debt
Accrued expenses
Accrued compensation
Operating lease liabilities – current
Derivative liabilities
Contingent liabilities - current (Note 7)
Other current liabilities
Nonrelated Party
Total other current liabilities
Other current liabilities – related party
Total current liabilities

Operating lease liabilities – noncurrent
Long-term convertible notes payable (Note 5)
Baker Notes
Total long-term convertible notes payable (Note 5)
Other noncurrent liabilities
Contingent liabilities - noncurrent (Note 7)
Total liabilities
Convertible and redeemable preferred stock
Series B1 Convertible Preferred Stock
Series B-2 Convertible Preferred Stock
Series C Convertible Preferred Stock
Total convertible and redeemable preferred stock

Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of both June 30, 2026 and December 31, 2025
Common Stock, $0.0001 par value; 3,000,000,000 shares authorized; 132,530,081 and 126,685,925 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ deficit
Total liabilities, convertible and redeemable preferred stock and stockholders’ deficit

Comments